10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      RNA demethylase ALKBH5 regulates hypopharyngeal squamous cell carcinoma ferroptosis by posttranscriptionally activating NFE2L2/NRF2 in an m 6A‐IGF2BP2‐dependent manner

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Having emerged as the most abundant posttranscriptional internal mRNA modification in eukaryotes, N6‐methyladenosine (m 6A) has attracted tremendous scientific interest in recent years. However, the functional importance of the m 6A methylation machinery in ferroptosis regulation in hypopharyngeal squamous cell carcinoma (HPSCC) remains unclear.

          Methods

          We herein performed bioinformatic analysis, cell biological analyses, transcriptome‐wide m 6A sequencing (m 6A‐seq, MeRIP‐seq), RNA sequencing (RNA‐seq), and RNA immunoprecipitation sequencing (RIP‐seq), followed by m 6A dot blot, MeRIP‐qPCR, RIP‐qPCR, and dual‐luciferase reporter assays.

          Results

          The results revealed that ALKBH5‐mediated m 6A demethylation led to the posttranscriptional inhibition of NFE2L2/NRF2, which is crucial for the regulation of antioxidant molecules in cells, at two m 6A residues in the 3′‐UTR. Knocking down ALKBH5 subsequently increased the expression of NFE2L2/NRF2 and increased the resistance of HPSCC cells to ferroptosis. In addition, m 6A‐mediated NFE2L2/NRF2 stabilization was dependent on the m 6A reader IGF2BP2. We suggest that ALKBH5 dysregulates NFE2L2/NRF2 expression in HPSCC through an m 6A‐IGF2BP2‐dependent mechanism.

          Conclusion

          Together, these results have revealed an association between the ALKBH5‐NFE2L2/NRF2 axis and ferroptosis, providing insight into the functional importance of reversible mRNA m 6A methylation and its modulators in HPSCC.

          Abstract

          RSL3‐induced head and neck cancer cell ferroptosis is closely correlated with the global m6A abundance. (a, b) Cell viability (a) and LDH release assays (b) of HNSCC cell lines that had been exposed to different concentrations of RSL3 for 24 h. (c) Measurement of cellular lipid ROS levels by BODIPY C11 staining after exposure to RSL3 for 24 h. (d) Western blot analysis of Detroit 562 and SCC25 cells exposed to various concentrations of RSL3 for 24 h. β‐Actin was used as the loading control. (e, f) Representative images of the m6A dot blot assay (e) and quantitation of m6A (f) showing the global m6A abundance in HNSCC cells. MB, methylene blue staining (as a loading control). (g) Heat map of HNSCC cells with hierarchical clustering of ferroptosis‐sensitive and ferroptosis‐insensitive cells; each value was normalized to the corresponding mean value.

          Related collections

          Most cited references51

          • Record: found
          • Abstract: found
          • Article: not found

          Ferroptosis: an iron-dependent form of nonapoptotic cell death.

          Nonapoptotic forms of cell death may facilitate the selective elimination of some tumor cells or be activated in specific pathological states. The oncogenic RAS-selective lethal small molecule erastin triggers a unique iron-dependent form of nonapoptotic cell death that we term ferroptosis. Ferroptosis is dependent upon intracellular iron, but not other metals, and is morphologically, biochemically, and genetically distinct from apoptosis, necrosis, and autophagy. We identify the small molecule ferrostatin-1 as a potent inhibitor of ferroptosis in cancer cells and glutamate-induced cell death in organotypic rat brain slices, suggesting similarities between these two processes. Indeed, erastin, like glutamate, inhibits cystine uptake by the cystine/glutamate antiporter (system x(c)(-)), creating a void in the antioxidant defenses of the cell and ultimately leading to iron-dependent, oxidative death. Thus, activation of ferroptosis results in the nonapoptotic destruction of certain cancer cells, whereas inhibition of this process may protect organisms from neurodegeneration. Copyright © 2012 Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

            Abstract Tremendous amount of RNA sequencing data have been produced by large consortium projects such as TCGA and GTEx, creating new opportunities for data mining and deeper understanding of gene functions. While certain existing web servers are valuable and widely used, many expression analysis functions needed by experimental biologists are still not adequately addressed by these tools. We introduce GEPIA (Gene Expression Profiling Interactive Analysis), a web-based tool to deliver fast and customizable functionalities based on TCGA and GTEx data. GEPIA provides key interactive and customizable functions including differential expression analysis, profiling plotting, correlation analysis, patient survival analysis, similar gene detection and dimensionality reduction analysis. The comprehensive expression analyses with simple clicking through GEPIA greatly facilitate data mining in wide research areas, scientific discussion and the therapeutic discovery process. GEPIA fills in the gap between cancer genomics big data and the delivery of integrated information to end users, thus helping unleash the value of the current data resources. GEPIA is available at http://gepia.cancer-pku.cn/.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Regulation of ferroptotic cancer cell death by GPX4.

              Ferroptosis is a form of nonapoptotic cell death for which key regulators remain unknown. We sought a common mediator for the lethality of 12 ferroptosis-inducing small molecules. We used targeted metabolomic profiling to discover that depletion of glutathione causes inactivation of glutathione peroxidases (GPXs) in response to one class of compounds and a chemoproteomics strategy to discover that GPX4 is directly inhibited by a second class of compounds. GPX4 overexpression and knockdown modulated the lethality of 12 ferroptosis inducers, but not of 11 compounds with other lethal mechanisms. In addition, two representative ferroptosis inducers prevented tumor growth in xenograft mouse tumor models. Sensitivity profiling in 177 cancer cell lines revealed that diffuse large B cell lymphomas and renal cell carcinomas are particularly susceptible to GPX4-regulated ferroptosis. Thus, GPX4 is an essential regulator of ferroptotic cancer cell death. Copyright © 2014 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                joelxm@zju.edu.cn
                Journal
                J Clin Lab Anal
                J Clin Lab Anal
                10.1002/(ISSN)1098-2825
                JCLA
                Journal of Clinical Laboratory Analysis
                John Wiley and Sons Inc. (Hoboken )
                0887-8013
                1098-2825
                11 June 2022
                July 2022
                : 36
                : 7 ( doiID: 10.1002/jcla.v36.7 )
                : e24514
                Affiliations
                [ 1 ] Department of Otolaryngology Head and Neck Surgery Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University Hangzhou Zhejiang China
                [ 2 ] Laboratory of Cancer Biology Institute of Clinical Science, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University Hangzhou Zhejiang China
                Author notes
                [*] [* ] Correspondence

                Mang Xiao, Sir Run Shaw Hospital, College of Medicine, Zhejiang University, East Qingchun Road Nr.3, Hangzhou, Zhejiang 310016, China.

                Email: joelxm@ 123456zju.edu.cn

                Author information
                https://orcid.org/0000-0002-7131-6251
                Article
                JCLA24514 JCLA-22-132.R2
                10.1002/jcla.24514
                9279968
                35689537
                5a9f3c7e-4bc7-4723-a91d-845c6f1626ab
                © 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 23 March 2022
                : 12 January 2022
                : 24 March 2022
                Page count
                Figures: 8, Tables: 0, Pages: 14, Words: 7568
                Funding
                Funded by: Medical Health Science and Technology Project of Zhejiang Provincial Health
                Award ID: 2020367813
                Funded by: Medical Health Science Project of Hangzhou
                Award ID: A20210546
                Award ID: OO20190775
                Funded by: National Natural Science Foundation of China , doi 10.13039/501100001809;
                Award ID: 62071415
                Funded by: National Youth Foundation of China , doi 10.13039/501100004492;
                Award ID: 81903160
                Funded by: Natural Science Foundation of Zhejiang Province , doi 10.13039/501100004731;
                Award ID: LY21H160031
                Categories
                Research Article
                Research Articles
                Custom metadata
                2.0
                July 2022
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.7 mode:remove_FC converted:14.07.2022

                Clinical chemistry
                alkbh5,ferroptosis,hpscc,m6a modification,nfe2l2/nrf2
                Clinical chemistry
                alkbh5, ferroptosis, hpscc, m6a modification, nfe2l2/nrf2

                Comments

                Comment on this article